John W. Brooker & Co. CPAs trimmed its holdings in The Procter & Gamble Company (NYSE:PG – Get Rating) by 7.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 42,977 shares of the company’s stock after selling 3,230 shares during the quarter. Procter & Gamble makes up approximately 4.3% of John W. Brooker & Co. CPAs’ holdings, making the stock its 5th biggest position. John W. Brooker & Co. CPAs’ holdings in Procter & Gamble were worth $6,523,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Keystone Wealth Services LLC grew its position in shares of Procter & Gamble by 2.7% during the 1st quarter. Keystone Wealth Services LLC now owns 2,562 shares of the company’s stock worth $381,000 after buying an additional 67 shares in the last quarter. Newbridge Financial Services Group Inc. grew its position in shares of Procter & Gamble by 1.8% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 3,824 shares of the company’s stock worth $580,000 after buying an additional 69 shares in the last quarter. Calton & Associates Inc. grew its position in shares of Procter & Gamble by 2.0% during the 4th quarter. Calton & Associates Inc. now owns 3,536 shares of the company’s stock worth $536,000 after buying an additional 71 shares in the last quarter. Bourgeon Capital Management LLC grew its position in shares of Procter & Gamble by 39.9% during the 4th quarter. Bourgeon Capital Management LLC now owns 249 shares of the company’s stock worth $38,000 after buying an additional 71 shares in the last quarter. Finally, Atticus Wealth Management LLC grew its position in shares of Procter & Gamble by 0.8% during the 4th quarter. Atticus Wealth Management LLC now owns 8,751 shares of the company’s stock worth $1,326,000 after buying an additional 71 shares in the last quarter. 64.65% of the stock is currently owned by institutional investors.
Procter & Gamble Trading Up 0.2 %
Procter & Gamble stock opened at $148.69 on Tuesday. The company has a quick ratio of 0.39, a current ratio of 0.59 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 52 week low of $122.18 and a 52 week high of $158.11. The company has a market capitalization of $350.46 billion, a price-to-earnings ratio of 25.90, a price-to-earnings-growth ratio of 4.13 and a beta of 0.41. The stock has a 50-day moving average price of $150.58 and a 200 day moving average price of $147.37.
Procter & Gamble Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, May 15th. Shareholders of record on Friday, April 21st were issued a $0.9407 dividend. The ex-dividend date of this dividend was Thursday, April 20th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.91. This represents a $3.76 dividend on an annualized basis and a yield of 2.53%. Procter & Gamble’s payout ratio is presently 65.51%.
Wall Street Analyst Weigh In
PG has been the topic of a number of recent research reports. Truist Financial downgraded Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price target for the stock from $165.00 to $155.00 in a research report on Thursday, May 18th. Evercore ISI increased their price target on Procter & Gamble from $160.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, April 24th. JPMorgan Chase & Co. raised Procter & Gamble from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $150.00 to $155.00 in a research report on Friday, March 3rd. StockNews.com assumed coverage on Procter & Gamble in a research note on Thursday, May 18th. They issued a “buy” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Procter & Gamble from $160.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, April 24th. Five analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $161.50.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CFO Andre Schulten sold 25,244 shares of the business’s stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $155.27, for a total value of $3,919,635.88. Following the completion of the transaction, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at $4,210,611.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Procter & Gamble news, CFO Andre Schulten sold 25,244 shares of the business’s stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $155.27, for a total value of $3,919,635.88. Following the completion of the transaction, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at $4,210,611.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Shailesh Jejurikar sold 31,000 shares of the company’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $156.03, for a total value of $4,836,930.00. Following the transaction, the chief operating officer now directly owns 10,014 shares of the company’s stock, valued at $1,562,484.42. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 95,093 shares of company stock valued at $14,821,930. 0.26% of the stock is owned by company insiders.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Featured Stories
- Get a free research report on Procter & Gamble from StockNews.com
- Is Diablo IV Causing a Resurgence in Activision Blizzard Stock?
- Sleep-At-Night Stock Sherwin-Williams Is Ready To Rebound
- MongoDB: An AI Play That’s About To Boil Over
- Will China’s $72 Billion EV Tax Breaks Help NIO Stock Recover?
- Five stocks we like better than Procter & Gamble
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Get Rating).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
